News
![Close-up image of a firm handshake between two colleagues](https://pharmaphorum.com/wp-content/uploads/2016/09/Handshake-generic.jpg)
Supernus bulks up its Parkinson's portfolio with Adamas take...
Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson's disease therapies to its stabl